爪真菌症(爪白癬)(Onychomycosis (Tinea Unguium))：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Onychomycosis (Tinea Unguium) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Onychomycosis (Tinea Unguium) to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Onychomycosis (Tinea Unguium) to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Onychomycosis (Tinea Unguium) 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Onychomycosis (Tinea Unguium) Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Onychomycosis (Tinea Unguium) 32
Sep 17, 2014: Moberg Pharma Announces Successful Results for MOB-015 in a Phase II Study for the Treatment of Onychomycosis 32
Sep 10, 2014: Data for Viamet’s VT-1161 Presented at ICAAC 2014 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Anacor Pharmaceuticals, Inc. 34
Clinical Trial Overview of Anacor Pharmaceuticals, Inc. 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
Valeant Pharmaceuticals International, Inc. 36
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 36
Moberg Pharma AB 37
Clinical Trial Overview of Moberg Pharma AB 37
Polichem S.A. 38
Clinical Trial Overview of Polichem S.A. 38
Hisamitsu Pharmaceutical Co., Inc. 39
Clinical Trial Overview of Hisamitsu Pharmaceutical Co., Inc. 39
Galderma S.A. 40
Clinical Trial Overview of Galderma S.A. 40
Apricus Biosciences, Inc. 41
Clinical Trial Overview of Apricus Biosciences, Inc. 41
Boehringer Ingelheim Auslandsbeteiligungs GmbH 42
Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 42
Clinical Trial Overview of Top Institutes / Government 43
Academia Espanola de Dermatologia y Venereologia 43
Clinical Trial Overview of Academia Espanola de Dermatologia y Venereologia 43
Homagama Base Hospital 44
Clinical Trial Overview of Homagama Base Hospital 44
Nanjing General Hospital of Nanjing Military Region 45
Clinical Trial Overview of Nanjing General Hospital of Nanjing Military Region 45
Malaga University 46
Clinical Trial Overview of Malaga University 46
Vesale Hospital 47
Clinical Trial Overview of Vesale Hospital 47
Pasteur Institute of Iran 48
Clinical Trial Overview of Pasteur Institute of Iran 48
University of Tasmania 49
Clinical Trial Overview of University of Tasmania 49
University of Brasilia 50
Clinical Trial Overview of University of Brasilia 50
Rady Children’s Hospital 51
Clinical Trial Overview of Rady Children’s Hospital 51
Helsinki University Central Hospital 52
Clinical Trial Overview of Helsinki University Central Hospital 52
Five Key Clinical Profiles 53
Appendix 85
Abbreviations 85
Definitions 85
Research Methodology 86
Secondary Research 86
About GlobalData 87
Contact Us 87
Disclaimer 87
Source 87